1. American Cancer Society: Cancer Facts and Figures 2006.
2. Herold-Mende C, Karcher J, Dyckhoff G, Schirrmacher V . Antitumor immunization of head and neck squamous cell carcinoma patients with a virus-modified autologous tumor cell vaccine. Adv Otorhinolaryngol 2005; 62: 173–183.
3. Hoffmann TK, Bier H, Donnenberg AD, Whiteside TL, De Leo AB . p53 as an immunotherapeutic target in head and neck cancer. Adv Otorhinolaryngol 2005; 62: 151–160.
4. Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES et al. Immunity to oncogenic proteins. Immunol Rev 1995; 145: 33–59.
5. Disis ML, Cheever MA . Oncogenic proteins as tumor antigens. Curr Opn Immunol 1996; 8: 637–642.